Semler Scientific, Inc.

Good afternoon, and welcome to the Semler Scientific Second Quarter 2022 Financial Results Conference Call. All participants will be in a listen-only mode. So, if you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then one on your touchtone phone. To withdraw from the question queue, please press star, then two. Please note, this event is being recorded. I would now like to introduce Doug Murphy, Tutorian, CEO of Semler Scientific. Please go ahead.

Good afternoon, everyone. Thank you for joining us for our second quarter 2022 results call. It is my pleasure to introduce you to Renee Comer, who joined Schlemeler in May as head of corporate communication and business strategy. Renee has had extensive experience in finance and accounting and was most recently on the buy side. Some of you have had the opportunity to speak to her already. Please welcome Renee.

Thank you, Doug. Good afternoon and thank you for joining us today. I'm excited to be here and looking forward to engaging with the investment community and our shareholders. In addition to Doug, with me today is Andy Weinstein, SVP, Finance and Accounting. Dennis Rosenberg could not join us today because he's battling COVID. We wish him a speedy recovery. Doug, Andy, and I will be available for Q&A following today's prepared remarks. Before we begin, I need to remind you that certain comments made during this call may constitute forward-looking statements and are made pursuant to and within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 as amended. These include statements regarding our expectations for expansion of our business and additional products, as well as our financial guidance. Such forward-looking statements are subject to both known and unknown risks and uncertainties that could cause actual results to differ materially from such statements. Those risks and uncertainties are described in the press release and our SEC filings. The forward-looking statements made today are as of the date of this call, and we do not undertake any obligation to update our forward-looking statements. If you do not have a copy of today's release, you may obtain one by visiting the investor relations page of our website, similarscientific.com. We're pleased to report that during the second quarter of 2022, the company reported record quarterly revenues and cash balances. We are beginning to see traction from the independent peer-reviewed study on Quantiflow, which was published in June 2022 in its final form. Orders from existing customers are increasing and we are receiving orders from new customers. I would now like to turn the call over to Andy to describe our financial performance in more detail. Andy?